Real-time enrollment status for this central nervous system lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 5:12 AM UTC
| NCT Number | NCT06175000 |
| Recruiting Status | Recruiting |
| Condition | Central Nervous System Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Providence Health & Services |
| Last Updated on CT.gov | June 5, 2025 (Jun 5, 2025) |
As of August 31, 2026: Clinical trial NCT06175000 is currently recruiting participants. This phase2 study for central nervous system lymphoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Providence Health & Services. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06175000 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06175000 was last updated Jun 5, 2025 (June 5, 2025). HelloStudys verifies this status automatically.